Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Portal Hypertension in Cirrhosis
NCT02994485Phase 4Completed
- Sponsor
- Tanta University
- Start
- Oct 2016
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Portal Hypertension (PH) (2 arms), sponsored by Tanta University. Primary endpoint: Number of Patients with Reduced Portal Pressure After Intervention at 6 months. Started Oct 2016; status: completed.
02
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT02994485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02994485.